T3	condition 78 111	intraductal proliferative lesions
T4	total-participants 691 694	177
T5	eligibility 695 730	recurrent nipple discharge patients
T6	intervention-participants 819 821	92
T7	control-participants 911 913	85
T8	control 935 948	control group
T9	outcome 1459 1532	agreement rate in the diagnosis of ductal intraepithelial neoplasia (DIN)
T10	outcome 1248 1284	benign mammary hyperplasia specimens
T11	outcome 1075 1109	benign mammary hyperplasia lesions
T1	intervention 23 73	fiberoptic ductoscopy plus in vivo iodine staining
T2	outcome 1534 1545	sensitivity
T12	outcome 1547 1558	specificity
T13	outcome 1560 1585	positive likelihood ratio
T14	outcome 1587 1612	negative likelihood ratio
T15	outcome 1618 1630	Youden index
T16	iv-bin-percent 1634 1640	97.82%
T17	iv-bin-percent 1642 1648	98.83%
T18	iv-bin-percent 1650 1656	83.33%
T19	iv-bin-percent 1658 1662	5.93
T20	iv-bin-percent 1664 1669	0.014
T21	iv-bin-percent 1675 1681	0.8216
T22	cv-bin-percent 1759 1765	88.24%
T23	cv-bin-percent 1767 1773	89.16%
T24	cv-bin-percent 1775 1781	50.00%
T25	cv-bin-percent 1783 1787	1.78
T26	cv-bin-percent 1789 1794	0.217
T27	cv-bin-percent 1800 1806	0.3916
